Posts for JUPITER NEUROSCIENCES, INC. ($JUNS)

Explore Jupiter Neurosciences, Inc.'s Q3 2024 financial report highlighting improved net loss, reduced R&D expenses, and ongoing operational risks. Ideal for investors assessing growth potential.

Explore Jupiter Neurosciences, Inc.'s 8-K filing dated December 17, 2024, detailing significant corporate events. Stay informed on crucial updates affecting shareholders.

Explore Jupiter Neurosciences, Inc.'s latest 8-K filing report, detailing company updates, market performance, and compliance as of December 15, 2024.